Raging Capital Management’s Pacific Biosciences PACB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-3,316,614	Closed	-$6.8M	–	31
2018 Q1	$6.8M	Buy	3,316,614 +125,519	+4%	+$326K	0.99%	27
2017 Q4	$8.42M	Sell	3,191,095 -1,232,968	-28%	-$4.32M	1.53%	28
2017 Q3	$23.2M	Sell	4,424,063 -710,937	-14%	-$3.06M	4.55%	9
2017 Q2	$18.3M	Buy	5,135,000 +193,288	+4%	+$779K	4.03%	14
2017 Q1	$25.5M	Buy	+4,941,712	New	+$24.2M	4.05%	15
2016 Q4	–	Sell	-2,818,004	Closed	-$25.2M	–	72
2016 Q3	$25.2M	Buy	2,818,004 +1,073,108	+61%	+$8.97M	4.34%	10
2016 Q2	$12.3M	Buy	+1,744,896	New	+$15.9M	2.13%	21
2015 Q4	–	Sell	-1,566,056	Closed	-$5.73M	–	47
2015 Q3	$5.73M	Buy	+1,566,056	New	+$7.66M	0.87%	26
2014 Q4	–	Sell	-1,579,097	Closed	-$7.75M	–	53
2014 Q3	$7.75M	Sell	1,579,097 -30,978	-2%	-$162K	1.22%	30
2014 Q2	$9.95M	Buy	1,610,075 +606,928	+61%	+$3.04M	1.6%	24
2014 Q1	$5.37M	Sell	1,003,147 -259,119	-21%	-$1.64M	1.05%	29
2013 Q4	$6.6M	Buy	1,262,266 +252,200	+25%	+$1.16M	1.51%	27
2013 Q3	$5.58M	Sell	1,010,066 -25,000	-2%	-$86.8K	1.41%	30
2013 Q2	$2.62M	Buy	+1,035,066	New	+$2.58M	0.74%	31